HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Posts Criteria For Targeting Executives As Responsible Officers

This article was originally published in The Tan Sheet

Executive Summary

FDA publishes criteria for filing criminal misdemeanor charges against executives from firms that break food and drug laws almost a year after the agency signaled its intent to pursue such cases.

You may also be interested in...



FDA Tainted Supplement Alert Could Set Stage For Rapid Enforcement

A week after FDA warned manufacturers about tighter enforcement against tainted dietary supplements, a MedWatch notice identifies an adulterated weight-loss product that appears to fit the agency's criteria for warranting regulatory action.

RAPS Annual Conference In Brief

FDA's supplement GMP focus evolves

Misdemeanor Charges Drive FDA's Park Doctrine Enforcement

FDA will push harder for federal prosecutors to take misdemeanor cases as the agency ramps up use of the Park Doctrine and strict liability statutes to prosecute corporate executives and others

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel